Login

Renren Inc., China's biggest networking website by page views, is discussed by Yoshikami with Emily Chang and Cory Johnson on 'Bloomberg West'. 00:10:00

Share On Facebook Share On Twitter

Joseph Chen and Chen Ji are the CEOs of Renren.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Tesla's Hydrogen-Powered Revolution|Elon Musk,CEO,Tesla
00:10:00
Emanuele Galtieri on Strategic Priorities and Investor Relations at CY4GATE | Emanuele Galtieri, CEO, CY4Gate SpA.
00:10:00
Interview with Jane Fraser, CEO of Citigroup
00:10:00
Browder Capital is a VC Firm led by Joshua Browder|Joshua Browder,Founder,Browder Capital
00:00:00
Collagen Solutions applies for European approval after successful ChondroMimetic study -Jamal Rushdy, Chief Executive Office, Collagen Solutions
00:10:00
Global Dynamics of Modern Christianity: From Europe to Asia and Beyond|Dr. Kenneth Calvert,Professor,Hillsdale College
00:10:00
Managing Director of Ubika Research Vikas Ranjan interviews Steven Palmer of AlphaNorth Asset Management, discussing views on capital markets, investment approach, and opportunities within the technology sector, particularly BSM Technologies Inc.
00:10:00
Captains of Industry ABN's Bronwyn Nielsen interviews Stephen Bradley Saad, Group CEO of Aspen, about the company's strategic vision and leadership.
00:10:00
Rugby Resources’ Gayle Simpson Highlights Exploration Projects and Track Record at Industry Forum
00:00:00
Peter Selin, CEO, Kancera
00:10:00
Nicolas Chartier on Growing Your Firm: Expert Advice from Aramis Group Co-Founder | Nicolas Chartier, Co-Founder, Aramis Group.
00:10:00
Aspen Group: Navigating the Affordable Accommodation Sector Amidst Economic Shifts|CEO , Aspen Group Ltd

© 2026 Nehu